[go: up one dir, main page]

DE69731883D1 - TRANSDERMALE SYSTEME ENTHALTEND ZWEI WIRKSTOFFE IN GETRENNTEN ABTEILUNGEN, IHRE HerstellungsVERFAHREN UND VERWENDUNG ALS ARZNEIMITTEL - Google Patents

TRANSDERMALE SYSTEME ENTHALTEND ZWEI WIRKSTOFFE IN GETRENNTEN ABTEILUNGEN, IHRE HerstellungsVERFAHREN UND VERWENDUNG ALS ARZNEIMITTEL

Info

Publication number
DE69731883D1
DE69731883D1 DE1997631883 DE69731883T DE69731883D1 DE 69731883 D1 DE69731883 D1 DE 69731883D1 DE 1997631883 DE1997631883 DE 1997631883 DE 69731883 T DE69731883 T DE 69731883T DE 69731883 D1 DE69731883 D1 DE 69731883D1
Authority
DE
Germany
Prior art keywords
medicaments
active substances
manufacturing processes
systems include
transdermal systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1997631883
Other languages
English (en)
Other versions
DE69731883T2 (de
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69731883D1 publication Critical patent/DE69731883D1/de
Application granted granted Critical
Publication of DE69731883T2 publication Critical patent/DE69731883T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
DE69731883T 1996-06-11 1997-06-10 TRANSDERMALE SYSTEME ENTHALTEND ZWEI WIRKSTOFFE IN GETRENNTEN ABTEILUNGEN, IHRE HerstellungsVERFAHREN UND VERWENDUNG ALS ARZNEIMITTEL Expired - Fee Related DE69731883T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9607209A FR2749514B1 (fr) 1996-06-11 1996-06-11 Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
FR9607209 1996-06-11
PCT/FR1997/001024 WO1997047305A1 (fr) 1996-06-11 1997-06-10 Systemes transdermiques renfermant deux principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
DE69731883D1 true DE69731883D1 (de) 2005-01-13
DE69731883T2 DE69731883T2 (de) 2005-12-22

Family

ID=9492920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731883T Expired - Fee Related DE69731883T2 (de) 1996-06-11 1997-06-10 TRANSDERMALE SYSTEME ENTHALTEND ZWEI WIRKSTOFFE IN GETRENNTEN ABTEILUNGEN, IHRE HerstellungsVERFAHREN UND VERWENDUNG ALS ARZNEIMITTEL

Country Status (19)

Country Link
EP (1) EP0904086B1 (de)
JP (1) JP2000511921A (de)
CN (1) CN1119150C (de)
AR (1) AR008229A1 (de)
AT (1) ATE284215T1 (de)
AU (1) AU739141B2 (de)
BR (1) BR9715082A (de)
CA (1) CA2257913A1 (de)
CZ (1) CZ295350B6 (de)
DE (1) DE69731883T2 (de)
ES (1) ES2235236T3 (de)
FR (1) FR2749514B1 (de)
NO (1) NO320999B1 (de)
PL (1) PL189361B1 (de)
RU (1) RU2209090C2 (de)
TR (1) TR199802577T2 (de)
TW (1) TWI228999B (de)
WO (1) WO1997047305A1 (de)
ZA (1) ZA975160B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
WO2006041907A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
EP1971325A2 (de) 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Konjugierte östrogen-zusammensetzungen, applikatoren, kits und verfahren zur ihrer herstellung und verwendung
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US10821297B2 (en) * 2016-09-30 2020-11-03 Johnson & Johnson Consumer Inc. Kit and method for topical delivery of benefits
JP6982960B2 (ja) * 2017-02-07 2021-12-17 リンテック株式会社 包材および包装体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
FR2749514B1 (fr) 1998-08-07
NO985807L (no) 1999-02-10
CZ410898A3 (cs) 1999-09-15
EP0904086B1 (de) 2004-12-08
CA2257913A1 (fr) 1997-12-18
TWI228999B (en) 2005-03-11
EP0904086A1 (de) 1999-03-31
ATE284215T1 (de) 2004-12-15
JP2000511921A (ja) 2000-09-12
NO985807D0 (no) 1998-12-11
BR9715082A (pt) 2003-07-15
AU3266197A (en) 1998-01-07
AR008229A1 (es) 1999-12-29
CN1227492A (zh) 1999-09-01
NO320999B1 (no) 2006-02-27
ZA975160B (en) 1998-06-11
RU2209090C2 (ru) 2003-07-27
AU739141B2 (en) 2001-10-04
FR2749514A1 (fr) 1997-12-12
WO1997047305A1 (fr) 1997-12-18
CN1119150C (zh) 2003-08-27
DE69731883T2 (de) 2005-12-22
TR199802577T2 (xx) 1999-03-22
PL330597A1 (en) 1999-05-24
CZ295350B6 (cs) 2005-07-13
ES2235236T3 (es) 2005-07-01
PL189361B1 (pl) 2005-07-29

Similar Documents

Publication Publication Date Title
DE69618959D1 (de) Pyrimidone und ihre verwendug als fungizide
DE59812907D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69912781D1 (de) Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
DE69600221D1 (de) Naphthalinderivate, ihre Herstellungsverfahren und Zwischenprodukte dafür, und diese enthaltende pharmazeutische Zusammensetzungen
DE122007000020I2 (de) Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwendung als pharmazeutische metallchelatoren
DE60023012D1 (de) 3(5)-amino-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE69827828T2 (de) Selbstexturierende, absorbierende strukturen und damit hergestellte absorbierende artikel
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
FI952359A0 (fi) Metalloseenikatalyyttisysteemit, niiden valmistaminen ja käyttö
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
ATE243708T1 (de) Substituierte imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE241612T1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
ATE224363T1 (de) Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung
DE69927033T2 (de) 4-aminopyridinderivate, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
ATE449786T1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69731883D1 (de) TRANSDERMALE SYSTEME ENTHALTEND ZWEI WIRKSTOFFE IN GETRENNTEN ABTEILUNGEN, IHRE HerstellungsVERFAHREN UND VERWENDUNG ALS ARZNEIMITTEL
DE69705622D1 (de) Distamycin derivate, verfahren zu ihrer herstellung sowie ihre verwendung als antitumor und antiviral wirkstoffe
DE69724453D1 (de) Camptothecine analoga, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen
HUP0101131A3 (en) Anti-inflammatory dihydrobenzopyran derivatives, medicaments containing the same, and their use
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE69006676D1 (de) Tripeptidverbindungen und ihre pharmazeutische Anwendung als Immunmodulatoren.
DE69918433D1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee